Abstract
Diet has a high relevance in health. Hypertension is a major risk factor for cardiovascular diseases and has an important impact on public health, and consequently on countries economy. Scientific research gathered strong evidence about the role of several dietary factors either in etiology or in treatment/prevention of these diseases. Peptides from different food matrices have been studied, and indicated as compounds with particular interest in the context of hypertension. The classical approach involves the identification of peptides with an in vitro ACE inhibitory activity and the assumption that the observed in vivo effects are due to this enzyme blockade. However, in some cases the potency of ACE blockade does not correlate with the antihypertensive activity in vivo. This paper reviews the current literature that identifies mechanisms of action, other than ACE inhibition, that might explain antihypertensive effects of biologically active peptides from different food sources.
Keywords: Bioactive peptides, biopeptides, mechanisms of action, hypertension, ACE, renin-angiotensin system, diet, cardiovascular diseases, enzyme blockade, antihypertensive activity.
Current Pharmaceutical Design
Title:Bioactive Peptides - Are There More Antihypertensive Mechanisms Beyond ACE Inhibition?
Volume: 18 Issue: 30
Author(s): Claudia Marques, Maria Manuela Amorim, Joana Odila Pereira, Manuela Estevez Pintado, Daniel Moura, Conceicao Calhau and Helder Pinheiro
Affiliation:
Keywords: Bioactive peptides, biopeptides, mechanisms of action, hypertension, ACE, renin-angiotensin system, diet, cardiovascular diseases, enzyme blockade, antihypertensive activity.
Abstract: Diet has a high relevance in health. Hypertension is a major risk factor for cardiovascular diseases and has an important impact on public health, and consequently on countries economy. Scientific research gathered strong evidence about the role of several dietary factors either in etiology or in treatment/prevention of these diseases. Peptides from different food matrices have been studied, and indicated as compounds with particular interest in the context of hypertension. The classical approach involves the identification of peptides with an in vitro ACE inhibitory activity and the assumption that the observed in vivo effects are due to this enzyme blockade. However, in some cases the potency of ACE blockade does not correlate with the antihypertensive activity in vivo. This paper reviews the current literature that identifies mechanisms of action, other than ACE inhibition, that might explain antihypertensive effects of biologically active peptides from different food sources.
Export Options
About this article
Cite this article as:
Marques Claudia, Manuela Amorim Maria, Odila Pereira Joana, Estevez Pintado Manuela, Moura Daniel, Calhau Conceicao and Pinheiro Helder, Bioactive Peptides - Are There More Antihypertensive Mechanisms Beyond ACE Inhibition?, Current Pharmaceutical Design 2012; 18 (30) . https://dx.doi.org/10.2174/138161212802651670
DOI https://dx.doi.org/10.2174/138161212802651670 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effect of Cardioembolic Etiology on Intravenous Thrombolysis Efficacy for Acute Ischemic Stroke
Current Neurovascular Research Current Status of Ethosomes and Elastic Liposomes in Dermal and Transdermal Drug Delivery
Current Pharmaceutical Design Antiobesity Therapy: Emerging Drugs and Targets
Current Medicinal Chemistry Genetics of Cholesterol and Lipoprotein Metabolism
Recent Patents on Cardiovascular Drug Discovery Glaucoma: Validated and Facile In Vivo Experimental Models of a Chronic Neurodegenerative Disease for Drug Development
Current Medicinal Chemistry - Central Nervous System Agents Heterozygosity in LDLR rs2228671 and rs72658855 Gene is Associated with Increased Risk of Developing Coronary Artery Disease in India –A Case-Control Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Cilostazol: A New Drug in the Treatment Intermittent Claudication
Recent Patents on Cardiovascular Drug Discovery Benefits of Exercise Training in Secondary Prevention of Coronary and Peripheral Arterial Disease
Vascular Disease Prevention (Discontinued) Clinical Trials: How to Assess Confounding and Why So
Current Clinical Pharmacology Meal Replacement Beverage Twice a Day in Overweight and Obese Adults (MDRC2012-001)
Current Nutrition & Food Science Pulmonary Disease in Beta-Thalassemia
Current Respiratory Medicine Reviews Subject Index To Volume 4
Cardiovascular & Hematological Agents in Medicinal Chemistry Evidence for the Involvement of Resistin in Inflammation and Cardiovascular Disease
Current Diabetes Reviews The Updated Role of the Blood Brain Barrier in Subarachnoid Hemorrhage: From Basic and Clinical Studies
Current Neuropharmacology Comparative Bioavailability of Two Oral Formulations of Clozapine in Steady State Administered in Schizophrenic Volunteers Under Individualized Dose Regime
Current Clinical Pharmacology Pharmacological Therapy of Pericardial Diseases
Current Pharmaceutical Design Sex, Stress and their Influence on Respiratory Regulation
Current Pharmaceutical Design Genetics of Vesicoureteral Reflux
Current Genomics Epigenetic Regulation Through SIRT1 in Podocytes
Current Hypertension Reviews Improved Sensory Blockade by Clonidine Added to Axillary Block Solution. Resulting Plasma Clonidine Concentration
Letters in Drug Design & Discovery